Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks
In one of his latest appearances on CNBC's Squawk on the Street, Jim Cramer started the morning by commenting on the latest Producer Price Index (PPI) release.
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 4,371 | $3,113,594 | -10% | 0.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $487.01 | 2,557 | 23,880,537 | 2017-08-25 | Filing | ||
| $485.99 | 2,681 | 23,877,980 | 2017-08-25 | Filing | ||
| $485.28 | 5,723 | 23,875,299 | 2017-08-25 | Filing | ||
| $484.21 | 2,000 | 23,869,576 | 2017-08-25 | Filing | ||
| $482.87 | 4,485 | 23,867,576 | 2017-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $844.61 | 1,000 | Officer | 12,931 | 2024-11-01 | Filing | |
| $1,059.28 | 2 | Director | 17,582 | 2024-10-01 | Filing | |
| $1,057.38 | 2 | Director | 17,584 | 2024-10-01 | Filing | |
| $1,056.68 | 3 | Director | 17,586 | 2024-10-01 | Filing | |
| $1,054.90 | 3 | Director | 17,589 | 2024-10-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,317,415 | $9,061,682,469 | 0.69% | |
| 2. | 8,838,285 | $7,762,577,333 | 0.16% | |
| 3. | 8,629,707 | $7,579,385,538 | 0.19% | |
| 4. | 7,226,769 | $6,347,199,734 | 0.67% | |
| 5. | 5,130,485 | $4,506,070,906 | 0.8% |
News See All
Jim Cramer's Bold Predictions About These 10 Healthcare Stocks
Healthcare has been one of Jim Cramer's favorite topics lately.
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Jim Cramer's Lightning Rounds: 12 Stocks Under the Spotlight
Jim Cramer, host of Mad Money, recently discussed the outlook for the stock market following a year of strong gains, cautioning that investors’ overly optimistic expectations for Federal Reserve rate...
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in six deaths worldwide.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2024 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2024 Earnings Call Transcript October 31, 2024Regeneron Pharmaceuticals, Inc. beats earnings expectations.
What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 High Growth NASDAQ Stocks That Are Profitable in 2024
Malcolm Ethridge, Capital Area Planning Group managing partner, joined CNBC to talk about where the market could go and his sentiment regarding the AI and overall tech sector.
Billionaire Hedge Funds
